Premium
Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki‐67 antibody
Author(s) -
MAZEROLLES C.,
RISHMANN P.,
CHOPIN D.,
POPOPIN Z.,
MALAVAUD B.,
SELVES J.,
NEULATDUGA I.,
BELLOT J.,
DELSOL G.
Publication year - 1994
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1111/j.1365-2559.1994.tb01375.x
Subject(s) - carcinoma , monoclonal antibody , antibody , pathology , immunohistochemistry , staining , urinary bladder , bladder cancer , ki 67 , biology , medicine , cancer , immunology
The reactivity of MIB1 antibody on routinely processed paraffin sections was compared with that of Ki‐67 antibody on frozen sections of 80 transitional cell carcinomas of the bladder. The percentage of labelled cells was expressed as the labelling index. MIB1 labelling indices were higher than those of Ki‐67 but for each case the two values were strongly correlated ( r = 0.91). Ki‐67 and MIB1 indices were also correlated to tumour grade and stage (P 0.001). MIB1 indices determined after both formaldehyde and ethanol based Bouin's fluid fixatives did not show any significant difference. MIB1 antibody staining after microwave oven heating of tissue sections is a simple technique for assessing the proliferative fraction of bladder tumours on fixed material. The use of MIB1 antibody permits retrospective studies and should determine whether the proliferation index in bladder carcinoma has the same prognostic value as demonstrated in other types of neoplasms.